Marvel Biosciences Corp Net Asset Momentum
Marvel Biosciences Corp net asset momentum. Marvel Biosciences Corp (MRVL) recorded a net asset momentum of -41.8% as of July 2025, with net assets of CA$-4.01 Million CAD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore debt repayment capacity of Marvel Biosciences Corp to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Marvel Biosciences Corp (2020–2025)
Net asset momentum of Marvel Biosciences Corp from 2020 to 2025. This chart tracks Marvel Biosciences Corp's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -41.8%, with net assets of CA$-4.01 Million CAD as of July 2025. See what is Marvel Biosciences Corp's book value for net asset value and shareholders' equity analysis.
Marvel Biosciences Corp Net Asset Momentum by Year (2020–2025)
Marvel Biosciences Corp net asset momentum by year from 2020 to 2025. The table below shows the complete annual net asset history for Marvel Biosciences Corp from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Marvel Biosciences Corp (MRVL) total market value.
| Year | Net Assets (CAD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CA$-4.01 Million | CA$326.71K | CA$4.33 Million | ▼ -41.8% |
| 2024 | CA$-2.83 Million | CA$491.31K | CA$3.32 Million | ▼ -64.3% |
| 2023 | CA$-1.72 Million | CA$672.39K | CA$2.39 Million | ▼ -979.7% |
| 2022 | CA$195.54K | CA$913.54K | CA$718.00K | ▼ -91.7% |
| 2021 | CA$2.36 Million | CA$2.47 Million | CA$112.48K | ▲ +1882.8% |
| 2020 | CA$118.80K | CA$295.99K | CA$177.18K | — |